SEI — Stockholm Environment Institute

Stockholm Environment Institute is an international non-profit research and policy organization that tackles environment and development challenges. We connect science and decision-making to develop solutions for a sustainable future for all. Our approach is highly collaborative: stakeholder involvement is at the heart of our efforts to build capacity, strengthen institutions, and equip partners for the long term. Our work spans climate, water, air, and land-use issues, and integrates evidence and perspectives on governance, the economy, gender and human health. Across our eight centres in Europe, Asia, Africa and the Americas, we engage with policy processes, development action and business practice throughout the world. - Do you want to work for SEI? Look at the career opportunities https://sei.org/jobs - Explore the SEI Strategy 2020–2024 at https://www.sei.org/strategy/2020-24/ - Learn more about the research at https://www.sei.org/

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR®), data-agnostic expertise, and a revolutionary engagement model, we deliver US and global real-world evidence, HEOR, and market access solutions that enable our partners to anticipate and address the evolving needs of payers, regulators, and stakeholders. Email solutions@genesisrg.com to find out more.

Nawah Scientific

Nawah is a core hub of advanced research equipment specialized in natural and medical sciences that offers its services online and on demand. Nawah's online platform receives experiments requests, Nawah's scientists carry them out and return results online. We serve industries in need of product development and analysis (Pharmaceuticals, Petro/Oil, chemicals, agriculture,...) as well as academics at universities in disciplines of life sciences (Biology, chem, pharma,…). Over 6 years of operation, Nawah has analyzed over 70K samples coming from 9 countries. We are a leading pharmaceutical formulation and analysis center in Egypt. Nawah’s business model is revolutionizing the scientific research ecosystem since scientists can now carry world class level of research regardless of the equipment available in their labs.

Candiolo Cancer Institute IRCCS

Opened in 1997, the Candiolo Institute is an oncological centre dedicated to clinical-healthcare activities and to scientific research. In 2013 it was granted the status of IRCCS (Institute for Admission and Care for Purposes of Scientific Advancement). It performs its activities both in arrangement with the Italian National Health Service and with private patients . In 2016 it obtained ISO quality certification 9001:2015 for all its areas of activity: diagnosis, treatment, assistance, research, administration, training, ethical committee. The care pathway of the patient undergoing a haematopoietic bone marrow transplant has obtained the prestigious international JACIE-FACT accreditation. In addition, the Institute can boast HIMSS (Healthcare Information Management Systems Society) certification reflecting high technological standards and security with in questions of digitization of clinical and administrative documentation. The Candiolo Institute has become, on the basis of a specific resolution of the Piedmont Regional Government dated 23.11.2015, a centre of reference for onco-haematological tumours, breast cancers, gynaecological tumours, colorectal tumours, tumours of the stomach, otorhinolaryngological tumours, urological tumours, skin cancers, sarcomas, tumours of the liver and of the intrahepatic bile ducts and tumours of the pancreas and of the extrahepatic bile ducts. In the course of 2015 Candiolo IRCCS also earned the role of regional single-specialty centre of reference for the management of oncological pain (DGR 29.12.2015). The IRCCS is authorized and accredited by the regional healthcare authority for the management of 150 beds: 70 in the medical area, 70 in surgery, and 10 in intensive care. In medical oncology, in addition to traditional chemotherapy, molecularly targeted therapies and immunotherapeutic treatments are also performed.

innovation place